DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada - Analyst Blog

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

Incyte: Increasing Sales, Deep Pipeline, Multiple Catalysts, With A Side Of M&A Chatter

5 Things Gilead Sciences, Inc. Management Wants You to Know

Analysis of comments from Gilead Sciences' president and COO.

Gilead Emerging Market Agreement: Huge Win For Patients, Non-Event For Investors.

Sector Update: Health-Care Shares Lower in Pre-Market Trade

Sector Update: Health Care

US Stock Futures Signal Higher Start On Wall Street

Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog

See More Articles...